Frontida BioPharm, Inc.
1100 Orthodox Street
Philadelphia
Pennsylvania
19124
United States
Website: http://frontidabiopharm.com/
About Frontida BioPharm, Inc.
Frontida BioPharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization supporting biopharmaceutical companies in the scale-up and commercial manufacture of immediate and controlled release oral solid dose products. Frontida offers the capability to manufacture Highly Potent Active Ingredient (HPAI) products, Combination Products, as well as DEA schedules II – V products. Its patented Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps, enhances drug loading, and creates better engineered and lower production-cost controlled release products.YEAR FOUNDED:
2015
LEADERSHIP:
CEO: Song Li
COO: Ron Connolly
JOBS:
Please click here for Frontida job opportunities.
3 articles about Frontida BioPharm, Inc.
-
Adare Pharma Solutions Acquires Frontida BioPharm to Expand Leading CDMO Offerings
12/1/2021
Adare Pharma Solutions, a technology-driven contract development and manufacturing organization, announced the acquisition of Frontida BioPharm, a vertically integrated CDMO focused on oral formulations.
-
Oncoceutics and Frontida BioPharm Announce Product Development and Commercialization Partnership
1/16/2018
Oncoceutics and Frontida BioPharm announced that the two companies have entered into a product development and commercialization agreement to further develop and scale-up the finished product manufacturing process for ONC201,
-
FDA Slaps Warning on Frontida BioPharm Plant
9/7/2016